Cargando…

Amino-Substituted 3-Aryl- and 3-Heteroarylquinolines as Potential Antileishmanial Agents

[Image: see text] Leishmaniasis, a disease caused by protozoa of the Leishmania species, afflicts roughly 12 million individuals worldwide. Most existing drugs for leishmaniasis are toxic, expensive, difficult to administer, and subject to drug resistance. We report a new class of antileishmanial le...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hammill, Jared T., Sviripa, Vitaliy M., Kril, Liliia M., Ortiz, Diana, Fargo, Corinne M., Kim, Ho Shin, Chen, Yizhe, Rector, Jonah, Rice, Amy L., Domagalska, Malgorzata A., Begley, Kristin L., Liu, Chunming, Rangnekar, Vivek M., Dujardin, Jean-Claude, Watt, David S., Landfear, Scott M., Guy, R. Kiplin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404201/ https://www.ncbi.nlm.nih.gov/pubmed/34355566 http://dx.doi.org/10.1021/acs.jmedchem.1c00813

Ejemplares similares

Discovery of novel, orally bioavailable, antileishmanial compounds using phenotypic screening
por: Ortiz, Diana, et al.
Publicado: (2017)

Arylquins Target Vimentin to Trigger Par-4 Secretion for Tumor Cell Apoptosis
por: Burikhanov, Ravshan, et al.
Publicado: (2014)

Semisynthetic aurones inhibit tubulin polymerization at the colchicine-binding site and repress PC-3 tumor xenografts in nude mice and myc-induced T-ALL in zebrafish
por: Xie, Yanqi, et al.
Publicado: (2019)

Induction of AMPK activation by N,N’-diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers
por: Johnson, Jeremy, et al.
Publicado: (2019)

Epigenetic Regulation of Wnt Signaling by Carboxamide-Substituted Benzhydryl Amines that Function as Histone Demethylase Inhibitors
por: Zhang, Wen, et al.
Publicado: (2020)

Antileishmanial, Antimicrobial and Antifungal Activities of Some New Aryl Azomethines
por: Al-Kahraman, Yasser M.S.A., et al.
Publicado: (2010)

2′,6′-Dihalostyrylanilines, Pyridines, and Pyrimidines for the Inhibition of the Catalytic Subunit of Methionine S-Adenosyltransferase-2
por: Sviripa, Vitaliy M., et al.
Publicado: (2014)

Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs
por: Rastrojo, Alberto, et al.
Publicado: (2018)

Antileishmanial Metabolites from Geosmithia langdonii
por: Malak, Lourin G., et al.
Publicado: (2014)

Synthesis of new 3-acetyl-1,3,4-oxadiazolines combined with pyrimidines as antileishmanial and antiviral agents
por: Lachhab, Saida, et al.
Publicado: (2022)

Nitroimidazooxazoles(#) Part xxiv, Search for Antileishmanial Agents: 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles as Potential Antileishmanial Agents
por: Shashiprabha,, et al.
Publicado: (2014)

A QSAR Study for Antileishmanial 2-Phenyl-2,3-dihydrobenzofurans †
por: Bernal, Freddy A., et al.
Publicado: (2023)

Clinical Pharmacokinetics of Systemically Administered Antileishmanial Drugs
por: Kip, Anke E., et al.
Publicado: (2017)

Improvement of Oral Bioavailability of Pyrazolo-Pyridone Inhibitors of the Interaction of DCN1/2 and UBE2M
por: Kim, Ho Shin, et al.
Publicado: (2021)

Second-generation pterocarpanquinones: synthesis and antileishmanial activity
por: Faiões, Viviane dos Santos, et al.
Publicado: (2018)

Synthesis and antileishmanial evaluation of some 2,3-disubstituted-4(3H)-quinazolinone derivatives
por: Birhan, Yihenew Simegniew, et al.
Publicado: (2014)

Developments in Diagnosis and Antileishmanial Drugs
por: Bhargava, Prachi, et al.
Publicado: (2012)

Synthesis, antimalarial, antileishmanial evaluation, and molecular docking study of some 3-aryl-2-styryl substituted-4(3H)-quinazolinone derivatives
por: Seifu, Girma Worku, et al.
Publicado: (2022)

1,3‐Bis(aryloxy)propan‐2‐ols as potential antileishmanial agents
por: Lavorato, Stefânia N., et al.
Publicado: (2017)

Synthesis of 4-substituted ethers of benzophenone and their antileishmanial activities
por: Ahad, Faiza, et al.
Publicado: (2018)

The Potential of 2-Substituted Quinolines as Antileishmanial Drug Candidates
por: Loiseau, Philippe M., et al.
Publicado: (2022)

Antileishmanial Drug Discovery and Development: Time to Reset the Model?
por: Olías-Molero, Ana Isabel, et al.
Publicado: (2021)

Synthesis, Structure and Antileishmanial Evaluation of Endoperoxide–Pyrazole Hybrids
por: Amado, Patrícia S. M., et al.
Publicado: (2022)

Discovery of a Diaminopyrimidine FLT3 Inhibitor Active against Acute Myeloid Leukemia
por: Jarusiewicz, Jamie A., et al.
Publicado: (2017)

Antileishmanial Aminopyrazoles: Studies into Mechanisms and Stability of Experimental Drug Resistance
por: Van den Kerkhof, M., et al.
Publicado: (2020)

4-Phenyl-1,3-thiazole-2-amines as scaffolds for new antileishmanial agents
por: Rodrigues, Carina Agostinho, et al.
Publicado: (2018)

The Antileishmanial Potential of C-3 Functionalized Isobenzofuranones against Leishmania (Leishmania) Infantum Chagasi
por: Pereira, Wagner Luiz, et al.
Publicado: (2015)

Non-Leishmania Parasite in Fatal Visceral Leishmaniasis–like Disease, Brazil
por: Domagalska, Malgorzata Anna, et al.
Publicado: (2020)

Strategies to Overcome Antileishmanial Drugs Unresponsiveness
por: Sundar, Shyam, et al.
Publicado: (2014)

Brazilian Propolis Antileishmanial and Immunomodulatory Effects
por: da Silva, Suelen Santos, et al.
Publicado: (2013)

Design and Synthesis of Novel Antileishmanial Compounds
por: Loedige, Melanie
Publicado: (2015)

Antileishmanial activity of 5-nitroindazole derivatives
por: Mollineda-Diogo, Niurka, et al.
Publicado: (2023)

Genomic and Phenotypic Characterization of Experimentally Selected Resistant Leishmania donovani Reveals a Role for Dynamin-1-Like Protein in the Mechanism of Resistance to a Novel Antileishmanial Compound
por: Hefnawy, Aya, et al.
Publicado: (2022)

New Vistas in the Biology of the Flagellum—Leishmania Parasites
por: Landfear, Scott M.
Publicado: (2022)

Antileishmanial Activity of Aldonamides and N-Acyl-Diamine Derivatives
por: Coimbra, Elaine S., et al.
Publicado: (2008)

Mining for natural product antileishmanials in a fungal extract library
por: Mbekeani, A.J., et al.
Publicado: (2019)

Hydrazone Derivatives Enhance Antileishmanial Activity of Thiochroman-4-ones
por: Vargas, Esteban, et al.
Publicado: (2017)

Antileishmanial Phenylpropanoids from the Leaves of Hyptis pectinata (L.) Poit
por: Falcao, Rosangela A., et al.
Publicado: (2013)

Evolution of Acridines and Xanthenes as a Core Structure for the Development of Antileishmanial Agents
por: Silva, Carlos F. M., et al.
Publicado: (2022)

Selecting an anti-malarial clinical candidate from two potent dihydroisoquinolones
por: Chen, Yizhe, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_60he4sa07kf9uono87c2dd8kf5